5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.98▼ | 2.00▼ | 2.00▼ | 2.15▼ | 2.07▼ |
MA10 | 2.03▼ | 2.04▼ | 2.04▼ | 2.17▼ | 2.33▼ |
MA20 | 2.06▼ | 2.08▼ | 2.13▼ | 2.18▼ | 4.45▼ |
MA50 | 2.21▼ | 2.18▼ | 2.16▼ | 2.57▼ | 15.15▼ |
MA100 | 2.19▼ | 2.22▼ | 2.25▼ | 4.51▼ | 116.56▼ |
MA200 | 2.30▼ | 2.44▼ | 2.63▼ | 12.89▼ | 19,229.65▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.011▼ | -0.016▼ | -0.020▼ | 0.027▲ | 1.813▲ |
RSI | 26.173▼ | 29.918▼ | 31.783▼ | 35.993▼ | 30.748▼ |
STOCH | 0.000▼ | 3.704▼ | 3.333▼ | 30.920 | 4.184▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
CCI | -198.211▼ | -270.821▼ | -262.581▼ | -125.779▼ | -83.378 |
Tuesday, August 19, 2025 12:45 PM
Jaguar Health, Inc. ( NASDAQ: JAGX) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Carol R. Lizak - Chief Financial Officer Lisa A. Conte - Founder, CEO, President & Director ...
|
Tuesday, August 19, 2025 09:42 AM
Based on the initial findings from the IIT in Abu Dhabi, crofelemer's paradigm-shifting mechanism of action has the potential to provide a novel therapeutic option to reduce parenteral support and ...
|
Thursday, August 14, 2025 06:58 AM
Jaguar Animal Health ( ($JAGX) ) just unveiled an update. On August 14, 2025, Jaguar Health, Inc. announced an amendment to its At the Market ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/08/25 | 2.05 | 2.05 | 1.90 | 1.90 | 158,974 |
18/08/25 | 2.10 | 2.11 | 2.02 | 2.07 | 44,738 |
15/08/25 | 2.12 | 2.12 | 2.02 | 2.10 | 110,700 |
14/08/25 | 2.31 | 2.31 | 2.06 | 2.07 | 269,900 |
13/08/25 | 2.45 | 2.60 | 2.32 | 2.59 | 152,300 |
12/08/25 | 2.17 | 2.65 | 2.159 | 2.35 | 265,100 |
11/08/25 | 2.16 | 2.17 | 2.10 | 2.17 | 43,700 |
08/08/25 | 2.10 | 2.1943 | 2.02 | 2.14 | 49,855 |
07/08/25 | 2.25 | 2.25 | 2.05 | 2.10 | 39,900 |
06/08/25 | 2.24 | 2.33 | 2.20 | 2.225 | 48,856 |
|
|
||||
|
|
||||
|
|